Abstract
The effect of circulating lupus anticoagulant on platelet interaction with collagen and other proteins was tested, with the aim of understanding the role of membrane phospholipids in platelet function. Plasma samples from 26 systemic lupus erythematosus (SLE) patients, containing circulating lupus anticoagulant (LAC), were examined for their effect on adhesion and aggregation of normal human platelets. We find that SLE plasma, but not normal plasma, inhibits platelet adhesion to collagen in a concentration-dependent manner. At a plasma concentration of 1% the inhibition was 73±9% (mean ± SD). In sharp contrast, there was no effect on platelet adhesion to fibronectin. Purified IgG from the same plasma samples also had an inhibitory effect. At 15 µg/ml (comparable in IgG concentration to 0.1% plasma) it inhibited adhesion to collagen by 33±11%. Inhibition could be abolished by preincubation of the LAC-containing plasma with cardiolipin (CL), phosphatidylinositol (PI), and, to a lesser extent, phosphatidylserine (PS) but not with phosphatidylcholine (PC) or phosphatidylethanolamine (PE). Inhibition could also be abolished by preincubation of the LAC-containing plasma with a 10-fold excess of washed normal platelets. The effect of 1% LAC plasma on platelet aggregation was as striking, showing 79±26% inhibition of collagen-induced aggregation, and it could also be abolished by preincubation of the LAC plasma with cardiolipin. In contrast, the effect of LAC plasma on thrombin-induced aggregation was rather modest. Our results indicate that antiphospholipid antibodies interfere with platelet adhesion and stimulation by collagenin vitro and point to an important role of external plasma membrane phospholipids, particularly PI, in collagen-induced platelet activation.
Similar content being viewed by others
References
Rosner E, Pauzner R, Lusky A, Modan M, Many A: Detection and quantitative evaluation of lupus circulating anticoagulant activity. Thromb Haemostas 57:144–147, 1987
Schleider MA, Nachman RL, Jaffe EA, Coleman M: A clinical study of the lupus anticoagulant. Blood 48:499–509, 1986
Thiagarajan P, Shapiro SS, De Marco L: Monoclonal immunoglobulin M coagulation inhibitor with phospholipid specificity. Mechanism of a lupus anticoagulant. J Clin Invest 66:397–405, 1980
Janoff AS, Rauch J: The structural specificity of anti-phospholipid antibodies in autoimmune disease. Chem Phys Lipids 40:315–332, 1986
Rauch J, Tannenbaum H, Senecal JL, Janoff AS, Cullis PR, Frojmovic MM: Polyfunctional properties of hybridoma lupus anticoagulant antibodies. J Rheum 14:132–137, 1987
Kelsey PR, Stevenson KJ, Poller L: The diagnosis of lupus anticoagulants by the activated partial thromboplastin time—the central role of phosphatidyl serine. Thromb Haemostas 52:172–175, 1984
Pengo V, Thiagarajan P, Shapiro SS, Heine MJ: Immunological specificity and mechanism of action of IgG lupus anticoagulants. Blood 70:69–76, 1987
Koike T, Tomioka H, Kumagai A: Antibodies cross-reactive with DNA and cardiolipin in patients with systematic lupus erythematosus. Clin Exp Immunol 50:2989–3002, 1982
Shoenfeld Y, Rauch J, Massicotte H, Datta SK, Andre-Schwartz J, Stollar BD, Schwartz RS: Polyspecificity of monoclonal lupus autoantibodies produced by human-human hybridomas. N Engl J Med 308:414–420, 1983
Schwartz RS, Stollar D: Origins of anti-DNA autoantibodies. J Clin Invest 75:321–327, 1985
Eilat D, Zlotnick AY, Fischel R: Evaluation of the cross-reaction between anti-DNA and anti-cardiolipin antibodies in SLE and experimental animals. Clin Exp Immunol 65:269–278, 1986
Eilat D: Anti-DNA antibodies: Problems in their study and interpretation. Clin Exp Immunol 65:215–222, 1986
Edberg JC, Taylor RP: Quantitative aspects of lupus anti-DNA autoantibody specificity. J Immunol 136:4581–4587, 1986
Marcus AJ: The role of lipids in blood coagulation. Adv Lipid Res 4:1–37, 1966
Broekman MJ, Handin RI, Derksen A, Cohen P: Distribution of phospholipids, fatty acids, and platelet factor 3 activity among subcellular fractions of human platelets. Blood 47:936–971, 1976
Schick PK, Kurica KB, Chacko GK: Location of phosphatidyl-ethanolamine and phosphatidylserine in the human platelet plasma membrane. J Clin Invest 57:1221–1226, 1976
Chap GHJ, Awaal RFA, van Deenen LLM: Action of highly purified phospholipases on blood platelets. Evidence for an asymmetric distribution of phospholipids in the surface membrane. Biochim Biophys Acta 467:146–164, 1977
Perret B, Chap HJ, Douste-Blazy L: Asymmetric distribution of arachidonic acid in the plasma membrane of human platelets. A determination using purified phospholipases and a rapid method for membrane isolation. Biochim Biophys Acta 556:434–446, 1979
Bevers EM, Comfurious P, Zwaal RFA: Changes in membrane phospholipid distribution during platelet activation. Biochim Biophys Acta 763:57–66, 1983
Wang C-T, Shiao Y-J, Chen J-C, Tsai W-J, Yang C-C: Estimation of the phospholipid distribution in the human platelet plasma membrane based on the effect of phospholipase A2 from Naja migricoolis. Biochim Biophys Acta 856:244–258, 1986
Wang C-T, Tsai W-J, Chang S-M, Shiao Y-J, Yang C-C: Different susceptibilities of platelet phospholipids to various phospholipases and modifications induced by thrombin. Possible evidence of rearrangement of lipid domains. Biochim Biophys Acta 899:205–212, 1987
Sömjen D, Zor U, Kaye AM, Harell A, Binderman I: Parathyroid hormone induction of creatine kinase activity and DNA synthesis is mimicked by phospholipase C, diacylglycerol and phorbol ester. Biochim Biophys Acta 931:215–223, 1987
Binderman I, Zor U, Kaye AM, Shimshoni V, Harell A, Sömjen D: The transduction of mechanical force into biochemical events in bone cells may involve activation of phospholipase A2. Calc Tissue Int 42:261–266, 1988
Lahav J, Shwartz MA, Hynes RO: Analysis of platelet adhesion using a radioactive chemical crosslinking reagent: Interaction of thrombospondin with fibronectin and collagen. Cell 31:253–262, 1982
Lahav J: Thrombospondin inhibits adhesion of platelets to glass and protein covered substrata. Blood 71:1096–1099, 1988
Hasselaar P, Derksen RHWM, Blokzijk L, de Groot PG: Thrombosis associated with antiphospholipid antibodies cannot be explained by effects on endothelial and platelet prostanoid synthesis. Thromb Haemostas 59:80–85, 1988
Racuh J, Meng Q-H, Tannenbaum H: Lupus anticoagulant and antiplatelet properties of human hybridoma autoantibodies. J Immunol 139:2598–2604, 1987
Harris FN, Gharavni AE: Anticardiolipin antibodies: Detection by radioimmunoassay and association with thrombosis in SLE. Lancet 2:1211–1214, 1983
Harris FN, Gharavni AE, Hughes GR: Antiphospholipid antibodies. Clin Rheumatol 591–609, 1985
Petri M, Rheinschmidt M, Whiting-O'Keefe Q, Hellman D, Corash L: The frequency of lupus anticoagulant in systematic lupus erythematosus. Ann Intern Med 524–531, 1987
Kroll MH, Schafer AI: Biochemical mechanisms of platelet activation. Blood 74:1181–1195, 1989
Takamura H, Narita H, Park HJ, Tanaka K-i, Matsura T, Kito M: Differential hydrolysis of phospholipid molecular species during activation of human platelets with thrombin and collagen. J Biol Chem 262:2262–2269, 1987
Kito M, Narita H, Ishinaga M, Park HJ, Takamura H: Phosphoinositide breakdown as an indirect link between stimulation and aggregation of rat platelets by thrombin and collagen. J Biochem 97:765–772, 1985
Piotrowicz RS, Orchekowski RP, Nugent DJ, Yamada KY, Kunicki TJ: Glycoprotein Ic-IIa functions as an activation-independent fibronectin receptor on human platelets. J Cell Biol 106:1359–1364, 1988
Clemetson KJ, Lüscher EF: Membrane glycoprotein abnormalities in pathological platelets. Biochim Biophys Acta 947:53–73, 1988
Lahav J: Platelet membrane component with high affinity for collagen. Thromb Haemostas 54:219 1985 (abstr.)
Klepfish A, Lahav J: Human platelet glycoprotein Ia has high affinity for collagen. Thromb Res VI:71 1986 (abstr.)
Niewenhuis HK, Akkerman JWN, Houdikj WPN, Sixma JJ: Human blood platelets showing no response to collagen fail to express surface glycoprotein Ia. Nature (London) 38:470–472, 1985
Nieuwenhuis K, Sakariassen KS, Houdijk WPM, Nievelstein FEM, Sixma JJ: Deficiency of platelet membrane glycoprotein Ia associated with a decreased platelet adhesion to subendothelium: A defect in platelet spreading. Blood 68:692–695, 1986
Kehrel B, Balleisen L, Kokott R, Mesters R, Stenziger W, Clemtson KJ, van de Loo J: Deficiency of intact thrombospondin and membrane glycoprotein Ia in platelet with defective collagen-induced aggregation and spontaneous loss of disorder. Blood 71:1074–1078, 1988
Coller BS, Beer JH, Scudder LE, Steinberg MH: Collagenplatelet interactions: Evidence for a direct interaction of collagen with platelet GPIa/IIa and an indirect interaction with platelet GPIIb/IIIa mediated by adhesive proteins. Blood 74:252–268, 1989
Moroi M, Jung SM, Okuma M, Shimmyozu K: A patient with platelet deficient in glycoprotein VI that lacks both collagen-induced aggregation and adhesion. J Clin Invest 84:1440–1445, 1989
Kraliz U, Tandon NN, Jamieson GA: Differential inhibition of early and late phases of platelet-collagen adhesion by anti GPIV. Thromb Haemostas 62:417 1989 (abstr.)
Lahav J, Dadosh-Goffer N, Schmilowitz H, Klepfish A: Platelet-collagen interaction involves the formation of disulfide bonds in GPIa. Thromb Haemostas 62:260 1989 (abstr.)
Shadle PJ, Ginsberg MH, Plow EF, Barondes SH: Platelet-collagen adhesion: Inhibition by a monoclonal antibody that binds glycoprotein IIb. J Cell Biol 99:2056–2060, 1984
Aihara M, Tamura K, Kawarada R, Okawa K, Yoshida Y: Glycoprotein Ib has a partial role in platelet-von Willebrand factor collagen interaction. Thromb Haemostas 60:182–187, 1988
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Ostfeld, I., Dadosh-Goffer, N., Borokowski, S. et al. Lupus anticoagulant antibodies inhibit collagen-induced adhesion and aggregation of human plateletsin vitro . J Clin Immunol 12, 415–423 (1992). https://doi.org/10.1007/BF00918853
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00918853